Abstract
Hepatic steatosis, a key feature of non-alcoholic fatty liver disease, is prevalent in various conditions such as obesity and type 2 diabetes mellitus. This systematic review aims to evaluate the effectiveness of olive oil on various hepatic health-related indicators. Six randomized controlled trials using olive oil for eating or cooking were included, totaling 344 individuals with a median age of 43 years and a mean baseline body mass index of 29.4, with 57.6% being male. Study durations ranged from 4 weeks to 6 months. In all four studies assessing hepatic steatosis grading through ultrasound, significant reductions were observed in the olive oil groups. Significant decreases in aspartate transaminase and alanine transaminase levels were reported in two studies. In conclusion, olive oil shows promise in ameliorating hepatic steatosis; however, further investigations are warranted to explore the potential effects of different olive oil types or olive polyphenols on chronic liver ailments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
